Binding of urokinase to the glycolipid-anchored urokinase receptor (uPAR) has been implicated in macrophage differentiation. However, no biochemical markers of differentiation have yet been directly linked to uPAR occupancy. As extensive changes in proteolytic profile characterize monocytic differentiation, we have examined the role of uPAR occupancy on protease expression by differentiating phagocytes. Antibodies to either urokinase or to uPAR that prevent receptor binding inhibited induction of cathepsin B in cultured monocytes and both cathepsin B and 92-kD gelatinase mRNA and protein in phorbol diester-stimulated myeloid cells. Mannosamine, an inhibitor of glycolipid anchor assembly, also blocked protease expression. Anti-catalytic urokinase antibodies, excess inactive urokinase, or aprotinin had no effect, indicating that receptor occupancy per se regulated protease expression. Antibodies to the integrins CD11a and CD29 or to the glycolipid-anchored proteins CD14 and CD55 also had no effect. Protease induction was independent of matrix attachment. Antibodies to urokinase or uPAR affected neither the decrease in cathepsin G nor the increase in tumor necrosis factor-a in phorbol esterstimulated cells. These data establish that uPAR is a multifunctional receptor, not only promoting pericellular proteolysis and matrix attachment, but also effecting cysteine-and metallo-protease expression during macrophage differentiation. (J. Clin. Invest. 1995. 96:465-474.)
Introduction
PMA treatment of the human leukemic cell lines HL-60, U937, and THP-1, arrested at various stages of development, is associ- 1 . Abbreviations used in this paper: cat B, cathepsin B; D3, 1, 25- (OH)2 vitamin D3; DFP, diisopropylfluorophosphate; E-64, L-transEpoxysuccinyl-leucylamido(4-guanido)butane; GPI, glycosylphosphatidylinositol; Y-A-CHN2, tyrosine-alanine-diazomethylketone; MA, mannosamine; MMP, matrix degrading metalloprotease; PAI, plasminogen activator inhibitor; s-uPAR, soluble urokinase receptor; uPA, urokinase; uPAR, urokinase receptor. ated with cessation of proliferation and acquisition of a differentiated, macrophage-like phenotype (1) (2) (3) . Among the many changes in gene expression that accompany the differentiation of these cells are striking changes in the expression of proteases (4) (5) (6) (7) (8) . These changes reflect the complex developmental control of proteases and presumably facilitate the functions of migratory progenitors and tissue macrophages. Unstimulated myeloid cells and fresh monocytes contain high levels of the serine proteases cathepsin G and human neutrophil elastase (HNE) (4, 9, 10) . Analogous to neutrophils, these serine proteases are stored in cytoplasmic granules and can be rapidly released in response to extracellular signals. In contrast, differentiated macrophages express little, if any, cathepsin G and HNE and are now able to express in a regulated manner metallo-and cysteineproteases (6, 7, 1 1 ) . Differentiation toward macrophages is also accompanied by increased expression of the serine protease urokinase-like plasminogen activator (uPA) and its cognate glycosylphosphatidylinositol (GPI) -anchored cell surface receptor (12) (13) (14) . Urokinase binds the first of the three homologous domains of (uPAR) and efficiently converts plasminogen at the cell surface to the broad-spectrum serine protease, plasmin ( 15, 16) . Plasmin, metalloproteases, and cysteine proteases cooperate with each other (17) to mediate the degradative functions of macrophages.
Receptor-bound uPA not only promotes pericellular proteolysis, but also, independent of its catalytic activity, promotes the adhesiveness of PMA-and cytokine-stimulated leukemic cells (18, 19) . We have recently reported that uPA-dependent adhesion is specific for vitronectin and that the urokinase receptor itself is a high affinity receptor for vitronectin (20, 21) . Urokinase appears to activate this adhesive function and thus adhesion is directly related to the number of uPA-bound receptors. Adhesion is not only a marker for but also is an integral part of macrophage differentiation, as adhesion modulates the expression of cytokines (TNFa, CSF-1, IL-1) and proto-oncogenes (c-fins, c-fos) (22, 23) . Thus, by promoting/regulating adhesion, the uPA/uPAR interaction may also modulate the expression of potent regulators of macrophage function, and indirectly influence the expression of genes important for differentiated macrophages. Potentially, uPAR occupancy may directly transduce signals, as has been documented for some GPI-anchored proteins (24, 25) , and influence the phenotype of macrophages. In fact, uPAR bound uPA has been demonstrated to induce cellular responses both dependent on (26, 27) and independent of (28) (29) (30) its catalytic activity.
The current study was undertaken to define the influence of uPAR occupancy on gene expression by differentiating phagocytes and to explore the cellular basis for such a function. We show for the first time that receptor-bound uPA can not only promote pericellular proteolysis, but can also directly influence the expression of cathepsin B (cat B) and the 92-kD gelatinase (matrix metalloprotease ) mRNA and protein during macrophage differentiation. These results extend the cooperation seen among distinct classes of proteases at the macrophage cell surface to regulation of their gene expression.
Methods
Reagents. RPMI (1) . In some experiments, D3 was used to enhance the response of U937 cells to PMA (31 ) . Mononuclear cells (PBMCs), isolated from heparinized (20 U/ml) venous blood (-60 ml) of healthy volunteers by Ficoll-Hypaque density separation, were cultured in RPMI 1640 containing 10% heat-inactivated heterologous human serum. All incubations were at 370C, 5% CO2, and cells were plated either at 106/ml (U937 and THP-1) or 5 X 106/ml (PBMCs). Unless otherwise indicated, all treatments were for 24 h and were carried out with 100 Ml cells/well in 96-well microtitre plates.
Cells were negative for mycoplasma as assessed by an enzyme detection kit (Mycotect; GIBCO BRL), and were greater than 95% viable as assessed by trypan blue exclusion. None of the treatments discussed below affected the viability of the cells. As JPM labeling (see below) indicated that low nM amounts of endotoxin inhibited the expression of active cat B in PMA-stimulated cells, all antibodies obtained either commercially or as gifts and used in cat B assays were determined to be negative for endotoxin as assessed by the limulus assay (E-Toxate kit; Sigma Chemical Co.). The R4 antibody, however, tested positive and was not used in the cat B assays. This antibody was used in the MMP-9 assay as endotoxin, if anything, increases MMP-9 expression.
Mannosamine treatment. To assess the affect of impaired GPI anchor synthesis, cells were stimulated with PMA in the presence of 10 mM mannosamine (MA) in regular, glucose (2 g/ml) containing RPMI, and 10% fetal bovine serum. In some experiments cells were incubated overnight with 2 mM MA before stimulus.
Triton X-114 phase separation of membrane proteins. Temperatureinduced phase separation in Triton X-1 14, initially described by Bordier (32) , has been used to characterize the GPI-anchored uPAR (33 transfected with a truncated, soluble version (residues 1-277) of human uPAR (s-uPAR), lacking the GPI-anchoring domain, as described elsewhere (21) . These cells were maintained in DME, 10% FBS and 50 pg/ml hygromycin. Conditioned medium free of serum and hygromycin, collected after an overnight culture of transfected cells in DME, was demonstrated to contain soluble uPAR that retained its ability to bind uPA. Conditioned medium thus collected was selectively depleted of soluble uPAR by using pro-uPA-coated immunoplates (Maxi-sorp Nunc Immunoplates; Marsh Biomedical Products, Inc., Rochester, NY). Briefly, the wells were coated overnight at 37°C with 1 jig pro-uPA per well (100 jl). After removing unbound pro-uPA from the wells, sequential incubations (100 jIL per well) of -1 h each resulted in the selective depletion of s-uPAR. The effect of normal and depleted conditioned media on PMA-stimulated U937 cells was studied by replacing RPMI with various concentrations (10-80%) of these media. Conditioned media obtained from nontransfected 293 cells and from 293 cells transfected with an irrelevant gene (antisense cathepsin D) were used as controls.
A similar approach was followed to selectively deplete the rabbit polyclonal anti-uPA antibody. The monoclonal anti-uPAR antibody, MA13, was selectively depleted using s-uPAR-conditioned mediumcoated plates.
Flow cytometry. An estimate of the extent of uPAR occupancy by uPA was obtained by using flow cytometry essentially as previously described (35) . Briefly, unstimulated and PMA-stimulated (24 h) U937 cells were resuspended in RPMI containing 2.5% FBS, and were incubated with the primary anticatalytic antibody (1:50) on ice for 30 min.
In some experiments cells were either incubated with 100 nM active uPA or acid-washed (19) before incubation with the primary antibody. After washing, cells were exposed to FITC-conjugated anti-mouse F(ab')2 fragments for 30 min on ice. The mean fluorescence of live cells was determined by using an Ortho Flow Cytometry 2151 system. Nonspecific fluorescence was obtained by using nonimmune mouse IgG as the primary antibody.
DFP-inactivation of uPA. uPA was inactivated with 5 mM DFP at room temperature for 1 h as previously described (18, 19) . Protein concentration of DFP-uPA was determined by A280 and confirmed by ELISA and total protein analysis. DFP treatment resulted in undetectable catalytic activity as measured by using a plasminogen-dependent fluorometric assay previously described (19) .
Assay for cysteine proteases. Expression of active lysosomal cysteine proteases was assessed by using class-specific active site probes. JPM, an analogue of the cysteine protease-specific inhibitor, L-transEpoxysuccinyl-leucylamido(4-guanido)butane (E-64), was iodinated using the lodagen protocol previously described (36) . For h at 37°C, 5% CO2. Cells were separated from the supernatant fluid and lysed in reduced sample buffer, subjected to SDS-PAGE and autoradiography. Extent of cat B induction was assessed by scanning densitometry using a CCD camera and NIH Image analysis software (MacIntosh II). In some instances cysteine protease activity was also assessed by using the fluorogenic dipeptide, Z-F-R-NMec, as substrate (6) .
Assay for metalloproteases. Secretion of metalloproteases by PMAstimulated myeloid cells was assessed by Western blotting. Cell-free culture media were mixed with 2x reduced sample buffer, boiled for 10 min, and subjected to SDS-PAGE (8%), followed by electrotransfer onto nitrocellulose. Nonspecific binding was blocked with 5% (wt/vol) nonfat dry milk powder and the membranes were sequentially treated with rabbit anti-MMP9 and goat anti-rabbit [1 I]IgG. After extensive washing, the membrane was subjected to autoradiography. The extent of MMP-9 induction was determined by scanning densitometry. In some experiments secretion of metalloproteases into the culture medium was assessed by zymography in 8% nonreducing SDS-PAGE containing 0.15% gelatin.
Assay for serine proteases. Expression of active serine proteases was assessed by using the irreversible, class-specific inhibitor, DFP (18, 19) .
Northern analysis. Whole cell RNA was isolated for analysis of steady state mRNA levels as previously described (19, 37 Lytic activity was assessed by measuring crystal violet uptake at 600 nm using an ELISA reader. Neutralizing anti-TNFa antibodies were used to ensure that all lytic activity in supernatants was due to TNFa.
Results
In agreement with previous results (4-11 ), in vitro macrophage differentiation, studied by using human myeloid cells as well as PBMCs, was accompanied by extensive changes in the profile of protease expression. The sections below detail the changes that are dependent upon autocrine uPAR occupancy.
Antibodies to uPAR and uPA inhibit cat B expression during macrophage differentiation. Expression of the 3 1-kD cat B-like protein increased in both stimulated U937 (Fig. 1 Fig. 1 B, were also observed by active-site labeling of human kidney 293 cells stably transfected with human cat B. Thus, these higher bands are likely to be precursor forms of cat B (Chapman, H. A., unpublished observation). This is consistent with the observation that precursors of the canonical cysteine protease, papain, are also labeled by E-64 analogues (39) . The influence of uPAR occupancy on the expression of the major form of active cat B (the 3 1-kD band) was investigated further.
In agreement with a recent report (35) , flow cytometry indicated that a substantial percentage (-50%) of the receptors in unstimulated U937 cells were occupied by endogenously produced uPA (not shown). Treatment with PMA for 24 h increased cell surface uPAR expression several-fold, but as expected the relatively modest increase in uPA expression resulted in the occupancy of only a small percentage of receptors (-10-25%). However, adding saturating amounts of uPA or receptorbinding fragments thereof did not alter the expression of either cathepsin B or MMP-9 (not shown). Thus, the effect of abrogating uPAR occupancy on protease expression was investigated.
Initial experiments indicated that polyclonal and mAbs to uPAR, made to the ligand-binding domain of the receptor, blocked PMA-induced adhesion of myeloid cells in a dosedependent manner. Furthermore, this block in adhesion could be overcome by DFP-uPA at concentrations shown previously to reverse the block in adhesion caused by anti-uPA ( 18) . Based on these observations an optimal concentration of antibodies was chosen to investigate the effect of uPAR occupancy on protease expression. Polyclonal (Fig. 1, lane 3) as well as monoclonal (Fig. 1, lanes 7 and 8) antibodies to uPAR inhibited PMA/D3-induced increase in cat B; nonimmune IgG was not inhibitory (Fig. 1, lane 4) removed much ('-60%) of the inhibitory activity of these antibodies (not shown).
In vitro culturing of PBMCs is accompanied by increases in plasminogen activator activity (40, 41) , cell surface uPAR (42) , as well as increased active cat B expression (Fig. 1, lane  10) . Therefore, we studied if a similar dependence for uPAR occupancy could be demonstrated in PBMCs. mAbs to uPAR, added at the start of culture, inhibited the expression of cat B (75±11%, n = 3) during a 24 h culture. Additionally, these antibodies also blocked the up-regulation of the cathepsin Slike protein (36) (Fig. 1 C) . Preliminary experiments showed that PMA-mediated increase of cat B protein in U937 cells is accompanied by a parallel increase in the steady-state level of cat B mRNA. Timecourse Northern analysis indicated that the increase in cat B mRNA (-18 h after stimulus) temporally followed the increase in uPA mRNA (-2-4 h after stimulus, not shown). Thus, we investigated if abrogating receptor occupancy by using anti-uPA, affects the steady-state levels of cat B mRNA. AntiuPA (but not nonimmune serum) consistently inhibited the PMA/D3-induced increase of cat B mRNA (Fig. 2 A) . Experiments done in parallel indicated that the pattern of active cat B expression correlated with levels of cat B mRNA (Fig. 2 B,  lanes 1-4) . Exogenous DFP-uPA reversed the anti-uPA-mediated block (Fig. 2 (43) . Thus, we sought to determine if uPAR occupancy influenced the expression of MMP-9 in U937 and THP-1 cells. In agreement with previous results (7, 11, 43) , the expression of the MMP-9 protein was enhanced several-fold in PMA-stimulated THP-1 cells (Fig. 3 A, lane 1 ) and U937 cells (Fig. 3  B, lanes 2 and 6) . As observed in the case of cat B, antibodies to uPA but not nonimmune serum inhibited phorbol ester-induced up-regulation of MMP-9 mRNA in both U937 (not shown) and THP-1 cells (Fig. 3 A, lanes 2 and 3) . Antibodies to the uPA receptor also inhibited the expression of MMP-9 in both THP-1 (not shown) and U937Vells (Fig. 3 B, lane 3) .
Essentially similar results were obtained by using gelatin zymography. The effect of these treatments on the secretion of MMP-9 by PBMCs was not evaluated as the increase in MMP-9 expression in these cells during short term in vitro culture is minimal. Analysis of the mechanism by which uPAR influences cat B and MMP-9 expression. Based on prior observations in other cellular systems that both the catalytic and receptor binding activities of uPA can elicit cellular responses (26-30), we questioned whether the uPA-and uPAR-dependent responses described above also required the catalytic activity of uPA. The addition of anti-catalytic urokinase antibodies at concentrations verified to block all cell surface uPA activity (10 pg/ml) had no effect on cat B or MMP-9 expression by PMA-stimulated U937 cells. The addition of the plasmin inhibitor aprotinin (250 KIU/ml) also did not inhibit the expression of cat B or MMP-9. Furthermore, the addition of excess (100 nM) DFP-inactivated uPA did not inhibit protease expression. Higher concentrations of this reagent could be expected to displace any active uPA from the cell surface. Together, these observations imply that the catalytic activity of uPA may not be directly involved in regulation of protease expression by these cells. This conclusion is supported by results with monoclonal antibodies directed against domains 2/3 of uPAR. Two such antibodies (R4 and R2 at 50 jig/ml) were tested (Table I) . Although the specific epitopes on domains 2/3 to which these antibodies are directed are unknown, neither antibody influences the uPAR-binding or catalytic activities of uPA (44) . One of these antibodies, R4, which has been shown to inhibit vitronectin binding to uPAR (21) also inhibited MMP-9 expression ('-50%) in PMA-stimulated U937 cells. Thus, anti-vitronectin antibodies were used to assess the role of vitronectin in PMA-induced adhesion and protease expression by U937 cells. Polyclonal anti-vitronectin antibodies were obtained from four different sources (Chemicon, Temecula, CA; GIBCO BRL; Becton Dickinson and Calbiochem Novabiochem, La Jolla, CA) and only those obtained from Calbiochem Novabiochem were observed to block the adhesion of PMA-stimulated U937 cells in a dose-dependent manner. However, antibodies at concentrations which block adhesion had no effect on protease expression. The specificity of antibodies directed against uPAR for inhibition of protease expression was tested by comparison with a variety of antibodies against other membrane or secreted proteins (Table I ). Antibodies to the integrins (CD1la, CD29), the GPI-anchored proteins (CD14, CD55), and secreted proteins (PAI-1), did not inhibit the expression of cat B and MMP-9.
To further assess the importance of uPAR occupancy on protease expression stimulated cells were exposed to a soluble form of uPAR. Soluble forms of cell surface receptors, including s-uPAR, can scavenge the endogenous ligands and thus inhibit occupancy of the cell surface form of the receptor (45) . As shown in Fig. 4 there is a dose-dependent inhibition in MMP-9 production (lanes 3, 4, 6, and 8). Moreover, depleting the s-uPAR-containing medium on pro-uPA-coated plates largely ablated the inhibitory affect (lanes 5, 7, and 9). Conditioned medium (especially at lower concentrations) obtained from cells transfected with an irrelevant protein, or medium from nontransfected cells did not have an inhibitory affect. Similarly, whereas s-uPAR was able to inhibit cat B in PMA-stimulated U937 cells, depleted s-uPAR was less so (not shown).
Cell surface form of uPAR is critical for protease expression. If the effects being studied are dependent on the cellsurface, GPI-anchored form of uPAR, releasing the anchor should result in a pronounced inhibition of the uPAR-dependent markers. Treatment of MDCK cells for a few hours with MA under glucose-free conditions converts GPI-anchored proteins to secretory products (46) . Significantly, treatment of stably transfected 293 cells expressing the GPI-anchored uPAR with 10 mM MA results in the partitioning of the protein into the aqueous phase (21) . However, as gene expression is an energy requiring process, initial experiments were directed at determining optimal MA doses under normal, glucose containing (2 g/ ml) culture conditions. Addition of MA at the start of culture inhibited, in a dose-dependent manner, the adhesion of 24 h PMA-stimulated myeloid cells to plastic. The concentration of MA that was able to optimally block adhesion without affecting cell viability was determined to be 10 mM (not shown). As shown in Fig. 5 A, 10 mM MA was a potent inhibitor of both cat B and MMP-9 expression in PMA-stimulated U937 cells. Similar results were obtained with the THP-1 cells as well (not shown). The possibility that the MA affect was an artifact of a net decrease in glucose uptake was eliminated by demonstrating that reducing glucose, in absence of MA, did not affect MMP-9 expression (not shown). Temperature-induced phase separation of membrane pellets in Triton X-1 14 indicated that MA treatment converts the GPI-anchored uPAR, normally seen largely in the detergent phase, into the soluble, aqueous phase (Fig. 5 B) .
The uPA-dependent processes ofadhesion and gene expression can be uncoupled. Adherence plays a pivotal role during the development of precursor cells into macrophages (22, 23) and acquisition of an adhesive phenotype is promoted by uPA that activates a high affinity vitronectin binding site on uPAR (19) (20) (21) . Therefore, we studied if attainment of adhesion itself is critical for cat B and MMP-9 up-regulation. Equal levels of active cat B were induced in 24 h PMA/D3-stimulated (compared to unstimulated) cells cultured either on adhesive plastic surfaces or on nonadhesive Teflon surfaces (9.8-and 8.7-foldincrease over unstimulated cells, respectively, n = 3). Similarly, no inhibition in cat B expression could be seen in PBMCs cultured on Teflon surfaces. Also, expression of MMP-9 was not impaired when PMA-stimulated U937 cells were cultured on Teflon (not shown). This divergence between the uPAdependent processes of adhesion and gene expression was explored further. As illustrated in Fig. 6 , adhesion of PMA/D3-stimulated U937 to plastic could be blocked by anti-uPA antibodies, whatever the time of addition. However, anti-uPA blocked cat B expression only when added during the first few hours after stimulus.
Antibodies to uPA and uPAR do not ablate the decrease in cathepsin G expression. 3H-DFP labeling of U937 and PBMC lysates indicated that the expression of a number of serine enzymes was altered during macrophage differentiation. As has been reported (7), the expression of the 26-kD cat G-like serine protease as well neutrophil elastase was greatly decreased during differentiation of both myeloid cells and PBMCs. However, PMA-mediated decrease in Cat G protein and mRNA was not affected by anti-uPA (not shown). Similarly, antibodies to uPA and uPAR did not affect the decrease in cat G protein in cultured PBMCs.
TNFa expression is not dependent on uPAR occupancy. Finally, we investigated whether uPAR occupancy influenced the expression of additional PMA-responsive genes. One such gene product is TNFa, a potent modulator of macrophage differentiation/activation. More specifically, TNFa enhances adhesion (3) and MMP-9 production in U937 cells (11) . Thus, it was possible that the uPA-dependent effects under study were being indirectly modulated by the changes in TNFa levels. In agreement with previous reports (38, 47) , we observed a several-fold induction of TNFa in 24 h PMA/D3-stimulated U937 cells. However, in contrast to adhesion and protease expression, anti-uPA did not affect the induction of TNFa (Fig. 7) Addition of anti-uPA post-stimulus (hours) Figure 6 . gous to thrombin (51, 52) (54) . However, the observation that the 39-kD LRPrelated protein (RAP), which blocks all such interactions, did not inhibit protease expression in PMA-stimulated cells (Rao, N., unpublished observation) makes it unlikely that the uPARmediated signaling under study operates via this pathway.
These findings raise the possibility that the recently identified novel function of uPAR as a high affinity receptor for vitronectin (21 ) (24, 56 ). An alternative mechanism for signaling via uPAR may involve caveolin, a 22-kD transmembrane protein that is an invariant component of membrane invaginations called caveolae (57, 58) . Interestingly, Western blots using specific mAbs to caveolin indicated that this 22-kD Previously reported work has implicated a relationship between matrix-degrading proteases such as cathepsins B and S, metalloproteases such as 92-kD gelatinase (MMP-9), and urokinase (17, 36, (62) (63) (64) (65) . At a functional level these distinct enzyme systems cooperate in extracellular matrix breakdown and in the cross-activation of their precursor forms. However, whether these interactions, which have been demonstrated in vitro, have any physiological relevance is unknown. Our observations, indicating cooperation among these distinct classes of proteins at the level of their own expression, supports a physiological role for these previously observed functional interactions (66) (67) (68) .
Significantly, not all PMA-induced responses are dependent on uPAR occupancy. Thus, anti-uPA did not affect the induction of either TNFa (Fig. 7) or CD18 (18) . Interestingly, TNFa potentiates MMP-9 expression in both unstimulated and PMAstimulated U937 cells (11) . Thus, our data raise the possibility that TNFa-mediated increase in MMP-9 production may also be influenced by concurrent uPAR occupancy.
Accumulating evidence indicates that the urokinase receptor is a multifunctional protein. Based on the data reported here and previous work by this and other laboratories, three distinct but interacting functions of uPAR can be advanced: (a) the receptor binds and concentrates urokinase at the cell surface where pericellular proteolysis may directly contribute to tissue remodelling and indirectly promote this process by activation of proenzymes and growth factors; (b) the receptor acts as a vitronectin receptor and promotes high affinity attachment of cells to the matrix-like form of vitronectin (21) . This function intrinsically links matrix attachment with regulation of cell surface uPA activity. This function may also contribute to the signaling properties of this receptor as cell-matrix interactions are known to alter cell shape and clustering of integrin receptors can mediate signals affecting the differentiation and function of many cell types (69) . However, our data are not easily explained by events secondary to adhesion, for the reasons stated above; ( 3 ) the receptor appears to either directly or cooperatively transduce signals and influence cellular differentiation/ activation by yet to be elucidated mechanisms. Indeed, uPAR occupancy, per se, independent of catalytic activity stimulates human osteosarcoma cell mitogenesis (28) , epidermal cell chemotaxis (29) , epithelial cell migration (30) , and bovine endothelial cell motility (70) . Furthermore, uPAR has been demonstrated to facilitate monocyte chemotaxis independent of uPA (71) and transfection of human kidney 293 cells with the GPIanchored form of uPAR, but not the soluble form of the protein, results in uPA-independent neosynthesis of a gelatin-degrading protease in these transfected cells (Rao, N., unpublished observation). Taken together these observations establish the multifunctional nature of cell surface uPAR. It is therefore tempting to speculate that deficiency in the expression of uPAR in patients suffering from paroxysmal nocturnal hemoglobinuria (72) may contribute not only to venous thrombosis but also to some of the other problems such as susceptibility to infection, increased incidence of leukemia, and a general disorder of hematopoiesis (73) , which characterize this disease.
